Subunit vaccines

Subunit vaccines are composed of protein or glycoprotein components of a pathogen that are capable of inducing a protective immune response and may be produced by conventional biochemical or recombinant DNA technologies. Recombinant subunit vaccines have distinct advantages over live attenuated and inactivated vaccines since they are efficient in inducing humoral- and cell-mediated immunological responses, and the risks associated with handling the pathogen are eliminated.

    Related Conference of Subunit vaccines

    February 20-21, 2023

    International Conference on Vaccine Research

    Madrid, Spain
    March 23-24, 2023

    6th International Conference on Vaccines, Immunology and Clinical Trials

    Amsterdam, Netherlands
    March 27-28, 2023

    International Conference on Vaccine & Vaccine Research

    San Diego, USA
    April 03-04, 2023

    6th International Conference on Vaccines and Immunology

    Paris, France
    May 22-23, 2023

    41st Euro Global Summit and Expo on Vaccines & Vaccination

    Berlin, Germany
    October 18-19, 2023

    43rd Global Summit and Expo on Vaccines & Immunology

    Vienna, Austria
    November 06-07, 2023

    5th World Congress on Vaccine and Immunology

    Tokyo, Japan

    Subunit vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in